Asghar Mesbahi1, Farideh Jamali, Nahideh Garehaghaji. 1. Medical Physics Department, Faculty of Medicine, Tabriz University of Medical sciences, Tabriz, Iran ; Radiation Oncology Department, Imam Hospital, Tabriz, Iran.
Abstract
INTRODUCTION: Gold nanoparticles have been used as radiation dose enhancing materials in recent investigations. In the current study, dose enhancement effect of gold nanoparticles on tumor cells was evaluated using Monte Carlo (MC) simulation. METHODS: We used MCNPX code for MC modeling in the current study. A water phantom and a tumor region with a size of 1×1×1 cm3 loaded with gold nanoparticles were simulated. The macroscopic dose enhancement factor was calculated for gold nanoparticles with sizes of 30, 50, and 100 nm. Also, we simulated different photon beams including mono-energetic beams (50-120 keV), a Cobalt-60 beam, 6 & 18 MV photon beams of a conventional linear accelerator. RESULTS: We found a dose enhancement factor (DEF) of from 1.4 to 3.7 for monoenergetic kilovoltage beams, while the DEFs for megavoltage beams were negligible and less than 3% for all GNP sizes and concentrations. The optimum energy for higher DEF was found to be the 90 keV monoenergetic beam. The effect of GNP size was not considerable, but the GNP concentration had a substantial impact on achieved DEF in GNP-based radiation therapy. CONCLUSION: The results were in close agreement with some previous studies considering the effect of photon energy and GNP concentration on observed DEF. Application of GNP-based radiation therapy using kilovoltage beams is recommended.
INTRODUCTION: Gold nanoparticles have been used as radiation dose enhancing materials in recent investigations. In the current study, dose enhancement effect of gold nanoparticles on tumor cells was evaluated using Monte Carlo (MC) simulation. METHODS: We used MCNPX code for MC modeling in the current study. A water phantom and a tumor region with a size of 1×1×1 cm3 loaded with gold nanoparticles were simulated. The macroscopic dose enhancement factor was calculated for gold nanoparticles with sizes of 30, 50, and 100 nm. Also, we simulated different photon beams including mono-energetic beams (50-120 keV), a Cobalt-60 beam, 6 & 18 MV photon beams of a conventional linear accelerator. RESULTS: We found a dose enhancement factor (DEF) of from 1.4 to 3.7 for monoenergetic kilovoltage beams, while the DEFs for megavoltage beams were negligible and less than 3% for all GNP sizes and concentrations. The optimum energy for higher DEF was found to be the 90 keV monoenergetic beam. The effect of GNP size was not considerable, but the GNP concentration had a substantial impact on achieved DEF in GNP-based radiation therapy. CONCLUSION: The results were in close agreement with some previous studies considering the effect of photon energy and GNP concentration on observed DEF. Application of GNP-based radiation therapy using kilovoltage beams is recommended.
Entities:
Keywords:
Gold nanopa Dose enhancement factor; Gold nanoparticle (GNP); Monte Carlo method; Radiation therapy
Authors: K T Butterworth; J A Coulter; S Jain; J Forker; S J McMahon; G Schettino; K M Prise; F J Currell; D G Hirst Journal: Nanotechnology Date: 2010-07-05 Impact factor: 3.874
Authors: Stephen J McMahon; Wendy B Hyland; Mark F Muir; Jonathan A Coulter; Suneil Jain; Karl T Butterworth; Giuseppe Schettino; Glenn R Dickson; Alan R Hounsell; Joe M O'Sullivan; Kevin M Prise; David G Hirst; Fred J Currell Journal: Radiother Oncol Date: 2011-09-15 Impact factor: 6.280
Authors: Nema Bassiri; Tara Gray; Shaquan David; Devanshi Yogeshkumar Patel; Andrew Locker; Karl Rasmussen; Niko Papanikolaou; Kathryn M Mayer; Neil Kirby Journal: Med Phys Date: 2019-11-19 Impact factor: 4.071
Authors: H Rabus; W B Li; C Villagrasa; J Schuemann; P A Hepperle; L de la Fuente Rosales; M Beuve; S Di Maria; A P Klapproth; C Y Li; F Poignant; B Rudek; H Nettelbeck Journal: Phys Med Date: 2021-03-23 Impact factor: 2.685
Authors: Kaspar Haume; Soraia Rosa; Sophie Grellet; Małgorzata A Śmiałek; Karl T Butterworth; Andrey V Solov'yov; Kevin M Prise; Jon Golding; Nigel J Mason Journal: Cancer Nanotechnol Date: 2016-11-03